The Düsseldorf-Geneva Treatment and Teaching Programme presents evidence-based standard for the therapy of Type 1 diabetes mellitus;Das Düsseldorf-Genfer strukturierte Therapie-und Edukations-Programm als Evidenz-basierter Standard für die Behandlung des Typ-1-Diabetes mellitus

Diabetes und Stoffwechsel

Volumn 10, Issue 3, 2001, Pages 105-110

  Berger, M ^a   Jorgens V ^a   Muhlhauser I ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Evidence based medicine; Intensified insulin therapy; Treatment and teaching programme; Type 1 diabetes mellitus

Indexed keywords

EID: 0038542149     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Cahill GF jr., Etzwiler DD, Freinkel N: ?Control" and diabetes. New Engl J Med 294 (1976) 1004-1005
2. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 329 (1993)977-986
3. Mühlhauser I, Berger M: Diabetes education and insulin therapy: when will they ever learn? J Internal Med 233 (1993) 321-326
4. Medical Research Council MRC: A framework for development and evaluation of RCTs for complex interventons to improve health. London, 2000
5. Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M: Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28 (1985) 602-613
6. Berger M: Bedarfsgerechte Insulintherapie bei freier Kost. Der Beitrag von Karl Stolte zur klinischen Diabetologie. Kirchheim Verlag, Mainz, 1999
7. Mühlhauser I, Jörgens V, Berger M et al.: Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25 (1983) 470-476
8. Mühlhauser I, Berger M, Sonnenberg GE, Koch J et al.: Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8 (1985) 268-273
9. Mühlhauser I, Klemm AB, Boor B, Scholz V, Berger M: Krankenhausaufenthalts- und Arbeitsunfähigkeitszeiten bei Patienten mit Typ 1 Diabetes. Einfluß eines Diabetes-Behandlungs- und Schulungsprogramms. Dtsch Med Wsch 111 (1986) 854-857
10. Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V et al.: Evaluation of an intensified treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 30 (1987)681-690
11. Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jörgens V, Bott U, Mühlhauser I, Berger M, Dedov II: Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for Type 1 (insulin-dependent) diabetes mellitus in Moscow - blood glucose versus urine glucose self-monitoring. Diabetologia 37 (1994) 170-176
12. Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M: Effective and safe translation of intensified insulin thertapy to general internal medicine departments. Diabetologia 36 (1993) 99-105
13. Mühlhauser I, Bott U, Overmann H, Wagener W, Bender R, Jörgens V, Berger M: Liberalized diet in patients with Type 1 diabetes. J Internal Med 237 (1995) 591-597
14. Bott S, Bott U, Berger M, Mühlhauser I: Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40 (1997) 926-932
15. Berger M, Mühlhauser I: Implementation of intensified insulin therapy: a European perspective. Diabetic Medicine 12 (1995) 201-208
16. Assad D, Puchulu R, Domenech MI, Mercuri N, Coppola L, Mazzei ME, Kronsbein P, Gagliardino JJ: Evaluación de un programa ambulatorio de educación y tratamiento de pacientes diabéticos insulinodependientes. Perspectivas diabetologicas 3 (1995) 19-22
17. Pieber T, Brunner CA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ: Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18 (1995) 625-630
18. Müller UA, Femerling M, Risse A, Reinauer KM, Voss M, Jörgens V, Berger M, Mühlhauser I: Intensified treatment and education of type-1-diabetes mellitus as clinical routine: a nation-wide quality circle experience in Germany. Diabetes Care 22, suppl. 2(1999) B29-B34
19. Müller UA, Köhler S, Femerling M, Risse A, Schumann M, Götz U, Niederau CM, Jörgens V, Berger M: Hba und schwere Hypoglykämien nach intensivierter Behandlung und Schulung von Patienten mit Typ-1-Diabetes als klinische Routine: Ergebnisse eines deutschlandweiten Qualitätszirkels (SD) 1992-1999. Diabetes & Stoffwechsel 9 (2000) 67-81
20. Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M: Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabetic Medicine 17 (2000) 727-734
21. Mühlhauser I, Sawicki PT, Blank M, Overmann H, Bender R, Berger M: Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy. J Internal Medicine 248 (2000) 333-341
22. Mühlhauser I, Overmann H, Bender R, Bott U, Jörgens V, Trautner C, Siegrist V, Berger M: Social quality and the quality of care for adult people with type-1 (insulin-dependent) diabetes - a population based study. Diabetologia 41 (1998) 1139-1150
23. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M: Risk factors of hypoglycaemia in adult patients with Type I diabetes - a prospective population based study. Diabetologia 41 (1998) 1274-1282
24. Haynes B: Can it work? Does it work? Is it worth it? Brit Med J 319 (1999) 652-653
25. Berger M, Mühlhauser I: Diabetes care and patient-oriented outcomes. J Am Med Ass 281 (1999) 1676-1678
26. Jack D: DAFNE - controlling diabetes the German way. Lancet 357 (2001) 1185